Paracentesis in the NEJM: Diagnostic and Therapeutic Approaches

Paracentesis in the NEJM: What Clinicians Need to Know

Paracentesis is a bedside procedure in which a needle is inserted through the abdominal wall to drain ascitic fluid. The New England Journal of Medicine has featured paracentesis in multiple review articles and case discussions, emphasizing its role in both diagnosing the cause of fluid accumulation and relieving the respiratory and abdominal distress caused by large-volume ascites. For hospitalists, gastroenterologists, and intensivists, understanding when and how to perform paracentesis safely is a core skill grounded in decades of published evidence.

Indications for Paracentesis

The procedure is indicated whenever ascites is new, worsening, or suspected to be infected. The most common diagnostic reason is to distinguish between portal hypertension from cirrhosis and other causes such as heart failure, nephrotic syndrome, peritoneal carcinomatosis, or tuberculosis. Therapeutically, large-volume paracentesis provides rapid relief when tense ascites causes dyspnea, early satiety, or abdominal wall compromise. The NEJM has repeatedly highlighted that therapeutic paracentesis should not be delayed when respiratory compromise is present, even while the underlying etiology is being worked up.

Diagnostic Evaluation of Ascitic Fluid

Once fluid is obtained, the initial laboratory panel typically includes cell count with differential, albumin, total protein, Gram stain, culture, and cytology. The serum-ascites albumin gradient (SAAG) is the single most useful metric: a SAAG of 1.1 g/dL or higher suggests portal hypertension, while a lower gradient points toward exudative causes. The NEJM reviews stress that a neutrophil count above 250 cells per cubic millimeter in an untreated patient is sufficient to diagnose spontaneous bacterial peritonitis and should trigger prompt antibiotic therapy.

Additional Fluid Studies

• Glucose and lactate dehydrogenase to evaluate for secondary peritonitis
• Amylase when pancreatic ascites or visceral perforation is suspected
• Culture volume enhancement, which the NEJM has noted improves yield in low-bacterial-load infections
• Cytology in patients with known or suspected malignancy

Technique and Safety Considerations

Ultrasound guidance is now standard practice for diagnostic and therapeutic paracentesis, reducing the risk of bowel or vessel injury. The procedure is typically performed with the patient in a supine or semi-recumbent position, using local anesthesia and a sterile field. A needle or catheter is advanced into the peritoneal cavity, and fluid is drained either by gravity or with a syringe. For large-volume therapeutic drainage, the NEJM literature supports the use of an 8-French or larger catheter and a controlled drainage rate, with albumin infusion administered when more than five liters are removed to reduce the risk of post-paracentesis circulatory dysfunction.

Complications and How to Mitigate Them

Major complications are uncommon but include hemorrhage, bowel perforation, catheter-related infection, and fluid leakage from the puncture site. Post-paracentesis circulatory dysfunction, characterized by a drop in effective arterial blood volume and activation of the renin-angiotensin-aldosterone system, can worsen renal function and increase mortality in cirrhotic patients. The NEJM has highlighted albumin replacement as an effective strategy to mitigate this hemodynamic shift when large volumes are removed.

Risk Reduction Checklist

• Correct coagulation status before the procedure
• Use ultrasound to identify the largest, safest fluid pocket
• Avoid multiple punctures at the same site
• Monitor vital signs and urine output during and after drainage
• Administer albumin according to institutional and guideline-based protocols

Evidence Base from NEJM Publications

Several landmark NEJM articles have shaped modern paracentesis practice. Randomized trials comparing albumin versus crystalloid solutions have shown that albumin reduces the incidence of post-paracentesis circulatory dysfunction without clearly improving long-term survival, leading to guideline recommendations that reserve albumin for the largest drainage volumes. Other studies published in the NEJM have demonstrated that early diagnostic paracentesis in cirrhotic patients with suspected infection is associated with lower mortality, reinforcing the message that the procedure should be performed promptly rather than deferred.

When Paracentesis Is Not Enough

While paracentesis is both diagnostic and therapeutic, it does not address the underlying cause of ascites. Patients with refractory ascites may require repeated procedures, transjugular intrahepatic portosystemic shunt creation, or evaluation for liver transplantation. In cases of secondary peritonitis or malignant ascites, the NEJM literature supports a multidisciplinary approach that pairs paracentesis with targeted pharmacologic or oncologic therapy.

Bottom Line for Clinicians

Paracentesis remains one of the most frequently performed invasive procedures in hospitalized patients with liver disease. The body of evidence published in the NEJM supports a structured approach: perform the procedure early when indicated, send a targeted fluid analysis, use ultrasound guidance, replace albumin when appropriate, and treat the underlying condition driving fluid accumulation. These principles translate directly into safer care and better outcomes for patients with ascites.